Tag: raw materials

Managing Supplier Grade Substitutions During Regulatory Reviews to Avoid Late-Stage Reformation In an evolving regulatory landscape, the risk of supplier grade substitution during the review process can significantly impact pharmaceutical…

Understanding Excipient Incompatibility with API: Preventing Late-Stage Reformulation As pharmaceutical companies continually strive for innovation and efficiency in formulation development, the challenges associated with excipient incompatibility with active pharmaceutical ingredients…

Addressing Functional Performance Failures During Stability Assessments Functional performance failures during stability assessments can lead to significant challenges in pharmaceutical manufacturing and quality assurance. These failures often signal potential issues…

Assessing Variability in Excipient Grade Through a Robust Supplier Qualification Process Variability in excipient grade during supplier qualification presents significant risks to pharmaceutical manufacturing quality, particularly concerning API compatibility and…

Understanding the Implications of Supplier Grade Substitution During Qualification: An Investigation In the dynamic environment of pharmaceutical manufacturing, supplier grade substitution poses significant challenges, especially during the qualification process. This…

Addressing Functional Performance Failures During Stability Assessments in Pharmaceutical Manufacturing Functional performance failures during stability assessments can significantly impact the integrity and compliance of pharmaceutical products. These failures often draw…

Investigating Variability in Excipient Grade During Regulatory Review The pharmaceutical industry relies heavily on excipients for drug formulation, and any variability during regulatory review can pose significant challenges. Understanding the…

Understanding Variability in Excipient Grades During Formulation Development In the pharmaceutical manufacturing process, variability in excipient grades can significantly impact drug formulation, leading to potential quality issues that attract scrutiny…

Understanding and Addressing Functional Performance Failures During Stability Assessments Functional performance failures during stability assessments pose significant risks to the pharmaceutical manufacturing process, potentially leading to late-stage reformulations or even…

Addressing Unjustified Excipient Choices in Formulation Development: An Investigation Approach In pharmaceutical manufacturing, the selection of excipients during formulation development is crucial for ensuring product quality. Unjustified excipient choices can…

Understanding Variability in the Grade of Excipients During Scale-Up and Its Regulatory Implications As pharmaceutical professionals, we often encounter inconsistencies in excipients that can significantly affect the quality and performance…